Critical appraisal:Berry MF, D'Amico TA, Onaitis MW, Kelsey CR 2014
From Cancer Guidelines Wiki
Critical Appraisal
Article being appraised
Berry MF, D'Amico TA, Onaitis MW, Kelsey CR. Thoracoscopic approach to lobectomy for lung cancer does not compromise oncologic efficacy. Ann Thorac Surg 2014 Jul;98(1):197-202 Available from: http://www.ncbi.nlm.nih.gov/pubmed/24820392.
Applicable clinical question
Key Facts
Study Design
case-control study
Study aims:
To compare survival between VATS and thoracotomy approaches to lobectomy for non-small cell lung cancer
Number of Patients:
560
Reported outcome(s):
5 year overall survival
Results of outcome(s):
5 year overall survival was similar for both groups; VATS 60.7% versus thoracotomy 54.8%, p= 0.5
Includes an economic evaluation
no
Evidence ratings
Level of evidence
III-2
Risk of bias
High risk of bias | Comments: Please replace this text and include any additional comments in regards to your quality rating |
Size of effect
3 | Reason for decision: Please replace this text and briefly describe the reasons for your rating |
Relevance of evidence
1 | Additional comments: Please replace this text and briefly describe the reasons for your rating |
Result of appraisal
Completed by
- Article
- Berry MF, D'Amico TA, Onaitis MW, Kelsey CR. Thoracoscopic approach to lobectomy for lung cancer does not compromise oncologic efficacy. Ann Thorac Surg 2014 Jul;98(1):197-202 Available from: http://www.ncbi.nlm.nih.gov/pubmed/24820392.
- Assigned to
- User:Gavin.wright
- Topic area
- Guidelines:Lung cancer/Treatment/Non-small-cell stage I operable
- Clinical question
Section below only relevant for Cancer Council Project Officer